Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting | Revista Portuguesa de Cardiologia (English edition)

Statistics

Original Article

Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting

Estudo de custo-efectividade de rivaroxabano para prevenção de acidente vascular cerebral em doentes com fibrilhação auricular em Portugal

João Moraisa, Carlos Aguiarb, Euan McLeodc, Ismini Chatzitheofilouc, Isabel Fonseca Santosd, Sónia Pereirad,

Corresponding author

sonia.pereira@bayer.com

Corresponding author.

a Hospital de Santo André, CHLP, Leiria, Portugal

b Hospital de Santa Cruz, CHLO, Carnaxide, Portugal

c IMS Health, London, United Kingdom

d Bayer Portugal, S.A., Carnaxide, Portugal

Read

8157

Times
was read the article

2171

Total PDF

5986

Total HTML

Share statistics

Article information

ISSN: 21742049
Original language: English

DOI:10.1016/j.repce.2014.02.021

The statistics are updated each day

Year/Month	Html	Pdf	Total

2025 6	22	4	26
2025 5	100	21	121
2025 4	62	20	82
2025 3	76	23	99
2025 2	55	29	84
2025 1	43	28	71
2024 12	56	23	79
2024 11	76	46	122
2024 10	37	29	66
2024 9	43	21	64
2024 8	49	24	73
2024 7	35	32	67
2024 6	30	27	57
2024 5	39	21	60
2024 4	38	27	65
2024 3	68	22	90
2024 2	63	29	92
2024 1	21	25	46
2023 12	24	17	41
2023 11	25	26	51
2023 10	37	30	67
2023 9	27	17	44
2023 8	31	21	52
2023 7	25	12	37
2023 6	25	8	33
2023 5	46	23	69
2023 4	22	4	26
2023 3	45	20	65
2023 2	41	19	60
2023 1	23	17	40
2022 12	47	27	74
2022 11	63	20	83
2022 10	39	16	55
2022 9	31	34	65
2022 8	59	31	90
2022 7	40	30	70
2022 6	34	25	59
2022 5	27	35	62
2022 4	38	36	74
2022 3	32	33	65
2022 2	32	25	57
2022 1	40	25	65
2021 12	18	31	49
2021 11	36	39	75
2021 10	29	39	68
2021 9	22	32	54
2021 8	25	24	49
2021 7	27	24	51
2021 6	17	18	35
2021 5	25	30	55
2021 4	51	38	89
2021 3	50	10	60
2021 2	43	17	60
2021 1	27	23	50
2020 12	39	11	50
2020 11	19	13	32
2020 10	11	14	25
2020 9	42	8	50
2020 8	22	6	28
2020 7	42	5	47
2020 6	26	9	35
2020 5	30	11	41
2020 4	34	11	45
2020 3	34	7	41
2020 2	92	31	123
2020 1	28	6	34
2019 12	41	8	49
2019 11	33	9	42
2019 10	37	5	42
2019 9	22	8	30
2019 8	31	7	38
2019 7	51	11	62
2019 6	32	17	49
2019 5	48	3	51
2019 4	26	17	43
2019 3	89	9	98
2019 2	85	17	102
2019 1	24	7	31
2018 12	50	9	59
2018 11	112	11	123
2018 10	467	14	481
2018 9	160	12	172
2018 8	87	8	95
2018 7	37	6	43
2018 6	42	12	54
2018 5	90	21	111
2018 4	97	8	105
2018 3	116	14	130
2018 2	91	5	96
2018 1	153	9	162
2017 12	218	6	224
2017 11	70	12	82
2017 10	31	17	48
2017 9	32	16	48
2017 8	29	14	43
2017 7	25	13	38
2017 6	45	7	52
2017 5	32	8	40
2017 4	40	2	42
2017 3	50	31	81
2017 2	35	8	43
2017 1	40	5	45
2016 12	34	11	45
2016 11	23	6	29
2016 10	31	6	37
2016 9	24	8	32
2016 8	8	2	10
2016 7	14	8	22
2016 6	10	11	21
2016 5	19	3	22
2016 4	24	11	35
2016 3	30	16	46
2016 2	47	22	69
2016 1	37	25	62
2015 12	47	23	70
2015 11	36	13	49
2015 10	44	27	71
2015 9	38	10	48
2015 8	26	11	37
2015 7	31	3	34
2015 6	25	8	33
2015 5	33	10	43
2015 4	23	14	37
2015 3	29	11	40
2015 2	15	4	19
2015 1	22	11	33
2014 12	33	19	52
2014 11	26	19	45
2014 10	34	14	48

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter